Press Releases April 24, 2026 12:00 PM

Hubbell Reports Regular Quarterly Dividend

Hubbell Incorporated Declares Regular Quarterly Dividend of $1.42 per Share

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
HUBB

Hubbell Incorporated announced that its Board of Directors has declared a quarterly dividend of $1.42 per share, payable on June 15, 2026, to shareholders of record as of May 29, 2026. The company, a leading manufacturer in the electrical and utility solutions sector, reported revenues of $5.8 billion in 2025.

Hubbell Reports Regular Quarterly Dividend
HUBB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Hubbell declares a quarterly dividend of $1.42 per share, signaling steady income for investors.
  • The dividend will be paid on June 15, 2026, with a record date set for May 29, 2026.
  • Hubbell reported revenues of $5.8 billion in 2025, reflecting its stable position in the electrical and utility markets.

Shelton, CT, April 24, 2026 (GLOBE NEWSWIRE) --

The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend of $1.42 per share on the Company’s common stock. The dividend will be paid on June 15, 2026 to shareholders of record on May 29, 2026.

Hubbell Incorporated is a leading manufacturer of utility and electrical solutions enabling customers to operate critical infrastructure reliably and efficiently. With 2025 revenues of $5.8 billion, Hubbell solutions electrify economies and energize communities in front of and behind the meter. The corporate headquarters is located in Shelton, CT.

Contact:     Dan Innamorato
                   Hubbell Incorporated
                   40 Waterview Drive
                   P.O Box 1000
                   Shelton, CT 06484


Risks

  • Dividend levels could be impacted by fluctuations in Hubbell's operational performance or economic conditions affecting the electrical utility sector.
  • Market interest rate changes may affect investor demand for dividend-paying stocks like Hubbell.
  • Potential regulatory changes or disruptions in infrastructure investment could influence Hubbell's future profitability and dividend sustainability.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026